Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#31 / 100 Total
HIMS - Hims & Hers Health Inc - Stock Price Chart
TickerHIMS [NYSE, RUT]
CompanyHims & Hers Health Inc
CountryUSA
IndustryHousehold & Personal Products
Market Cap2.41BEPS (ttm)-0.11
P/E-EPS this Y200.87%
Forward P/E27.63EPS next Y267.30%
PEG-EPS past 5Y-
P/S2.77EPS next 5Y-
P/B6.99EPS Q/Q110.59%
Dividend-Sales Q/Q47.50%
Insider Own34.85%Inst Own38.55%
Insider Trans-3.91%Inst Trans4.54%
Short Float12.51%EarningsMay 06/a
Analyst Recom1.92Target Price16.02
Avg Volume5.27M52W Range5.65 - 17.16
Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Baird MelissaChief Operating OfficerMay 03 '24Option Exercise0.4011,7504,700550,682May 03 06:38 PM
Baird MelissaChief Operating OfficerMay 03 '24Sale11.6411,750136,826538,932May 03 06:38 PM
Baird MelissaChief Operating OfficerMay 02 '24Option Exercise0.4011,7504,700550,682May 03 06:38 PM
Baird MelissaChief Operating OfficerMay 02 '24Sale12.0811,750141,923538,932May 03 06:38 PM
Dudum AndrewChief Executive OfficerMay 01 '24Option Exercise2.43188,888458,998188,888May 03 06:38 PM
DTIL - Precision Biosciences Inc - Stock Price Chart
TickerDTIL [NASD]
CompanyPrecision Biosciences Inc
CountryUSA
IndustryBiotechnology
Market Cap42.71MEPS (ttm)-18.25
P/E-EPS this Y41.06%
Forward P/E-EPS next Y41.09%
PEG-EPS past 5Y7.97%
P/S0.88EPS next 5Y-
P/B2.32EPS Q/Q47.27%
Dividend-Sales Q/Q-33.59%
Insider Own11.14%Inst Own65.43%
Insider Trans-43.75%Inst Trans-66.79%
Short Float9.69%EarningsMar 27/b
Analyst Recom1.33Target Price33.00
Avg Volume131.65K52W Range8.25 - 27.02
Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's proprietary genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane on January 26, 2006 and is headquartered in Durham, NC.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Amoroso MichaelPresident and CEOMay 02 '24Sale10.321,52615,74813,772May 03 06:29 PM
List AlanChief Medical OfficerMay 02 '24Sale10.322902,9934,488May 03 06:30 PM
Scimeca DarioGeneral Counsel and SecretaryMay 02 '24Sale10.322722,8075,680May 03 06:33 PM
SMITH J. JEFFERSONChief Research OfficerMay 02 '24Sale10.321541,58967,613May 03 06:32 PM
List AlanChief Medical OfficerApr 30 '24Sale10.032382,3863,796Apr 30 06:34 PM
DXLG - Destination XL Group Inc - Stock Price Chart
TickerDXLG [NASD, RUT]
CompanyDestination XL Group Inc
CountryUSA
IndustryApparel Retail
Market Cap187.89MEPS (ttm)0.43
P/E7.54EPS this Y-48.00%
Forward P/E10.80EPS next Y15.38%
PEG0.50EPS past 5Y-
P/S0.36EPS next 5Y15.00%
P/B1.26EPS Q/Q-33.23%
Dividend-Sales Q/Q-4.68%
Insider Own12.16%Inst Own82.69%
Insider Trans-4.15%Inst Trans8.28%
Short Float8.78%EarningsMar 21/b
Analyst Recom2.00Target Price5.25
Avg Volume268.48K52W Range3.12 - 5.36
Destination XL Group, Inc. is engaged in the retail of specialty products. It offers shirts, pants, shorts, outerwear, activewear, suiting, underwear and lounge, shoes, and accessories. It distributes its products under the following brand names: Destination X, DXL, DXL Men's Apparel, DXL Outlets, Casual Male XL, and Casual Male XL Outlets. It operates through the Stores, and Direct Businesses segments. The company was founded by Calvin Margolis and Stanley I. Berger in 1976 and is headquartered in Canton, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fund 1 Investments, LLC10% OwnerMay 03 '24Sale3.15225,000708,7955,691,577May 03 06:32 PM
REATH JAMESChief Marketing OfficerApr 01 '24Option Exercise0.002,583013,463Apr 10 04:25 PM
Stratton Peter H Jr.EVP, CFO, TreasurerApr 01 '24Option Exercise0.004,5600231,948Apr 10 04:25 PM
Molloy Robert SGeneral Counsel & SecretaryFeb 15 '24Option Exercise0.5320,00010,600260,409Feb 16 04:30 PM
Molloy Robert SGeneral Counsel & SecretaryFeb 15 '24Sale4.0020,00080,006240,409Feb 16 04:30 PM
EWTX - Edgewise Therapeutics Inc - Stock Price Chart
TickerEWTX [NASD, RUT]
CompanyEdgewise Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap1.82BEPS (ttm)-1.57
P/E-EPS this Y-8.84%
Forward P/E-EPS next Y-19.06%
PEG-EPS past 5Y-68.02%
P/S-EPS next 5Y-
P/B4.31EPS Q/Q-51.60%
Dividend-Sales Q/Q-
Insider Own32.59%Inst Own64.22%
Insider Trans1.99%Inst Trans17.24%
Short Float9.15%EarningsFeb 22/b
Analyst Recom1.00Target Price32.60
Avg Volume736.60K52W Range5.12 - 20.90
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Donovan Joanne M.CMOMay 02 '24Sale18.913,68269,62719,897May 03 06:27 PM
KOCH KEVINPresident and CEOMay 02 '24Sale18.913,15259,60414,478May 03 06:26 PM
Carruthers R MichaelChief Financial OfficerMay 02 '24Sale18.912,15740,78935,230May 03 06:30 PM
MOORE JOHN RGeneral CounselMay 02 '24Sale18.911,95636,9883,252May 03 06:31 PM
Derakhshan BehradChief Business OfficerMay 02 '24Sale18.911,71832,48713,422May 03 06:29 PM
ZM - Zoom Video Communications Inc - Stock Price Chart
TickerZM [NASD]
CompanyZoom Video Communications Inc
CountryUSA
IndustrySoftware - Application
Market Cap19.01BEPS (ttm)2.05
P/E30.10EPS this Y-5.51%
Forward P/E12.28EPS next Y2.23%
PEG20.07EPS past 5Y-
P/S4.20EPS next 5Y1.50%
P/B2.37EPS Q/Q368.46%
Dividend-Sales Q/Q2.56%
Insider Own24.23%Inst Own56.54%
Insider Trans-0.35%Inst Trans-0.54%
Short Float5.48%EarningsFeb 26/a
Analyst Recom2.63Target Price78.03
Avg Volume3.49M52W Range58.87 - 75.90
Zoom Video Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Steckelberg KellyChief Financial OfficerMay 01 '24Sale61.425,007307,5190May 03 06:28 PM
Bawa AparnaChief Operating OfficerApr 18 '24Sale60.1821,9681,322,0271,978Apr 22 06:40 PM
Steckelberg KellyChief Financial OfficerApr 17 '24Sale59.365,007297,2030Apr 19 06:19 PM
Yuan Eric S.Chief Executive OfficerApr 11 '24Sale62.452,420151,12392,720Apr 12 06:13 PM
Yuan Eric S.Chief Executive OfficerApr 10 '24Sale61.9827,9631,733,12995,140Apr 12 06:13 PM
RXRX - Recursion Pharmaceuticals Inc - Stock Price Chart
TickerRXRX [NASD, RUT]
CompanyRecursion Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap2.10BEPS (ttm)-1.55
P/E-EPS this Y-9.14%
Forward P/E-EPS next Y-7.82%
PEG-EPS past 5Y-43.41%
P/S47.10EPS next 5Y12.00%
P/B4.46EPS Q/Q-28.81%
Dividend-Sales Q/Q-20.36%
Insider Own31.78%Inst Own71.84%
Insider Trans-1.51%Inst Trans4.55%
Short Float23.89%EarningsMay 09/a
Analyst Recom2.43Target Price13.00
Avg Volume6.39M52W Range4.55 - 16.75
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel medicines. Its Recursion operating system enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, novel chemistry, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics that radically improve people's lives. The company was founded by Blake Borgeson, Christopher C. Gibson, and Dean Y. Li on November 5, 2013 and is headquartered in Salt Lake City, UT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Gibson ChristopherChief Executive OfficerMay 02 '24Sale8.4750,000423,500834,820May 03 06:24 PM
Gibson ChristopherChief Executive OfficerMay 01 '24Sale7.7350,000386,500863,524May 03 06:24 PM
Borgeson BlakeDirectorApr 30 '24Sale7.9511,44790,9647,218,414May 02 05:41 PM
Marriott TinaPresident and COOApr 25 '24Option Exercise1.063,0003,180546,231Apr 29 06:41 PM
Marriott TinaPresident and COOApr 25 '24Sale7.673,00023,020543,231Apr 29 06:41 PM
GDDY - Godaddy Inc - Stock Price Chart
TickerGDDY [NYSE]
CompanyGodaddy Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap17.62BEPS (ttm)12.03
P/E10.28EPS this Y-33.77%
Forward P/E19.90EPS next Y1.96%
PEG-EPS past 5Y84.46%
P/S4.08EPS next 5Y-3.30%
P/B42.45EPS Q/Q812.62%
Dividend-Sales Q/Q7.34%
Insider Own0.73%Inst Own91.45%
Insider Trans-19.64%Inst Trans-1.86%
Short Float1.78%EarningsMay 02/a
Analyst Recom1.84Target Price140.02
Avg Volume1.45M52W Range67.43 - 127.15
GoDaddy, Inc. engages in the provision of simple and easy-to-use products on a single technology platform wrapped with personalized guidance. It operates under the Applications and Commerce (A and C) and Core Platform (Core) segments. The A and C segment includes selling products containing proprietary software, commerce products, third-party email, productivity solutions, and certain products included in bundled offerings of proprietary software products. The Core segment includes domain registrations and renewals, aftermarket domain sales, website hosting products, website security products not included in bundled offerings of proprietary software, and products that do not contain a software component. The company was founded by Robert R. Parsons in 1997 and is headquartered in Tempe, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chen RogerChief Operating OfficerMay 01 '24Sale122.604,000490,400200,632May 03 06:23 PM
McCaffrey MarkChief Financial OfficerApr 02 '24Sale120.8362475,401116,328Apr 03 09:18 PM
Chen RogerChief Operating OfficerApr 01 '24Sale118.564,000474,240204,632Apr 03 09:18 PM
Bhutani Amanpal SinghChief Executive OfficerMar 21 '24Sale120.002,500300,000384,323Mar 25 06:27 PM
Bhutani Amanpal SinghChief Executive OfficerMar 08 '24Sale113.807,600864,880386,823Mar 11 07:13 PM
PLTR - Palantir Technologies Inc - Stock Price Chart
TickerPLTR [NYSE]
CompanyPalantir Technologies Inc
CountryUSA
IndustrySoftware - Infrastructure
Market Cap52.08BEPS (ttm)0.09
P/E258.36EPS this Y32.08%
Forward P/E58.73EPS next Y20.29%
PEG-EPS past 5Y-
P/S23.41EPS next 5Y-
P/B14.77EPS Q/Q182.86%
Dividend-Sales Q/Q19.61%
Insider Own15.27%Inst Own39.49%
Insider Trans-4.02%Inst Trans4.18%
Short Float4.12%EarningsMay 06/a
Analyst Recom3.20Target Price20.43
Avg Volume68.19M52W Range7.28 - 27.50
Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates under the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Moore Alexander D.DirectorMay 01 '24Sale22.0220,000440,3061,595,519May 03 06:16 PM
Palantir Technologies Inc.Former 10% OwnerApr 24 '24Sale0.3718,6216,9725,233,625Apr 24 08:25 PM
Palantir Technologies Inc.Former 10% OwnerApr 23 '24Sale0.3718,4716,7925,252,246Apr 24 08:25 PM
Palantir Technologies Inc.Former 10% OwnerApr 22 '24Sale0.343,2001,0895,270,717Apr 24 08:25 PM
Palantir Technologies Inc.10% OwnerApr 19 '24Sale0.3412,0864,1435,273,917Apr 19 09:09 PM
TNET - TriNet Group Inc - Stock Price Chart
TickerTNET [NYSE, RUT]
CompanyTriNet Group Inc
CountryUSA
IndustryStaffing & Employment Services
Market Cap5.11BEPS (ttm)6.10
P/E16.57EPS this Y-23.64%
Forward P/E14.71EPS next Y15.31%
PEG2.27EPS past 5Y19.89%
P/S1.04EPS next 5Y7.30%
P/B35.77EPS Q/Q-18.28%
Dividend0.25%Sales Q/Q1.44%
Insider Own2.72%Inst Own96.96%
Insider Trans-4.99%Inst Trans-0.24%
Short Float2.40%EarningsApr 26/b
Analyst Recom2.00Target Price124.00
Avg Volume255.13K52W Range87.20 - 134.67
TriNet Group, Inc. engages in the provision of comprehensive human resources solutions for small and medium-size businesses. The firm also offers access to human capital expertise, benefits, risk mitigation, compliance, payroll, and research and development tax credit services. The company was founded by Martin Babinec in 1988 and is headquartered in Dublin, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chamberlain Paul EdwardDirectorMay 01 '24Sale101.0237537,88236,341May 03 06:12 PM
Goldfield Burton M.DirectorFeb 22 '24Sale124.6316,2002,018,956364,479Feb 26 06:26 PM
WELLINGTON SAMANTHAEVP, CLO and SECRETARYFeb 22 '24Sale124.8814,2711,782,23148,562Feb 26 06:27 PM
LOWELL WAYNE BDirectorFeb 21 '24Sale122.2210,0001,222,23084,766Feb 23 04:34 PM
TUMINELLI KELLY LEVP & CHIEF FINANCIAL OFFICERFeb 21 '24Sale122.674,396539,23565,999Feb 23 06:08 PM
CDNS - Cadence Design Systems, Inc. - Stock Price Chart
TickerCDNS [NASD, NDX, S&P 500]
CompanyCadence Design Systems, Inc.
CountryUSA
IndustrySoftware - Application
Market Cap76.64BEPS (ttm)3.84
P/E73.38EPS this Y15.18%
Forward P/E40.44EPS next Y17.42%
PEG4.13EPS past 5Y25.42%
P/S18.80EPS next 5Y17.75%
P/B21.48EPS Q/Q2.27%
Dividend-Sales Q/Q-1.23%
Insider Own0.88%Inst Own89.07%
Insider Trans-12.98%Inst Trans0.95%
Short Float0.91%EarningsApr 22/a
Analyst Recom1.83Target Price325.87
Avg Volume1.61M52W Range198.92 - 327.36
Cadence Design Systems, Inc. engages in the design and development of integrated circuits and electronic devices. The company was founded by Alberto Sangiovanni-Vincentelli, Gudmundur A. Hjartarson, K. Bobby Chao, and K. Charles Janac in June 1988 and is headquartered in San Jose, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cunningham PaulSr. Vice PresidentMay 01 '24Sale275.361,000275,36067,144May 03 06:03 PM
Nisewaner KarnaSVP & General CounselMay 01 '24Sale275.36600165,21620,480May 03 06:04 PM
SANGIOVANNI VINCENTELLI ALBERTDirectorApr 15 '24Sale308.831,500463,23850,183Apr 17 05:21 PM
Cunningham PaulSr. Vice PresidentApr 01 '24Sale310.461,000310,46068,144Apr 03 05:25 PM
Nisewaner KarnaSVP & General CounselApr 01 '24Sale310.46600186,27621,080Apr 03 05:20 PM
12345678910